Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.
Cohen R, Vernerey D, Bellera C, Meurisse A, Henriques J, Paoletti X, Rousseau B, Alberts S, Aparicio T, Boukovinas I, Gill S, Goldberg RM, Grothey A, Hamaguchi T, Iveson T, Kerr R, Labianca R, Lonardi S, Meyerhardt J, Paul J, Punt CJA, Saltz L, Saunders MP, Schmoll HJ, Shah M, Sobrero A, Souglakos I, Taieb J, Takashima A, Wagner AD, Ychou M, Bonnetain F, Gourgou S, Yoshino T, Yothers G, de Gramont A, Shi Q, André T; ACCENT Group. Cohen R, et al. Among authors: saunders mp. Eur J Cancer. 2020 May;130:63-71. doi: 10.1016/j.ejca.2020.02.009. Epub 2020 Mar 12. Eur J Cancer. 2020. PMID: 32172199 Free PMC article.
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.
Van Cutsem E, Yoshino T, Lenz HJ, Lonardi S, Falcone A, Limón ML, Saunders M, Sobrero A, Park YS, Ferreiro R, Hong YS, Tomasek J, Taniguchi H, Ciardiello F, Stoehr J, Oum'Hamed Z, Vlassak S, Studeny M, Argiles G. Van Cutsem E, et al. Among authors: saunders m. Ann Oncol. 2018 Sep 1;29(9):1955-1963. doi: 10.1093/annonc/mdy241. Ann Oncol. 2018. PMID: 30010751 Free PMC article. Clinical Trial.
Engineering immunity using metabolically active polymeric nanoparticles.
Griffin KV, Saunders MN, Lyssiotis CA, Shea LD. Griffin KV, et al. Among authors: saunders mn. Trends Biotechnol. 2024 Dec 27:S0167-7799(24)00345-7. doi: 10.1016/j.tibtech.2024.11.016. Online ahead of print. Trends Biotechnol. 2024. PMID: 39732608 Review.
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM.
Kamposioras K, Ntellas P, Dadouli K, Christodoulis E, Adamou M, Anderson D, Shanthappa A, Connell J, Williams J, Simpson L, Germetaki T, Braun M, Barriuso J, Hasan J, Mullamitha S, Marti K, Saunders M, Lim KHJ. Kamposioras K, et al. Among authors: saunders m. Curr Oncol. 2024 Dec 11;31(12):7903-7913. doi: 10.3390/curroncol31120582. Curr Oncol. 2024. PMID: 39727705 Free PMC article.
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set.
Samuel R, Knight SR, Adams R, Das P, Dorth J, Finch D, Guren MG, Hawkins MA, Moug S, Rajdev L, Sebag-Montefiore D, Renehan AG, Fish R; plus the CORMAC-2 collaborators. Samuel R, et al. EClinicalMedicine. 2024 Dec 5;78:102939. doi: 10.1016/j.eclinm.2024.102939. eCollection 2024 Dec. EClinicalMedicine. 2024. PMID: 39720423 Free PMC article. Review.
Molecular and niche modeling approaches to identify potential amplifying hosts for an emerging tick-borne pathogen, Rickettsia rickettsii subsp. californica, the causative agent of Pacific Coast tick fever.
Mai V, Boria RA, Padgett K, Koo MS, Saunders MEM, Billeter S, Asin J, Shooter S, Zambrano M, Karpathy S, Paddock CD, Swei A. Mai V, et al. Among authors: saunders mem. J Med Entomol. 2024 Dec 17:tjae147. doi: 10.1093/jme/tjae147. Online ahead of print. J Med Entomol. 2024. PMID: 39688497
1,735 results